PARIS, and BOULDER (Colorado, United States), December 20, 2023 -6:00 p.m. CET – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), innovative company which deploys its digital real-time surgical guidance (DSG) technology to secure and simplify the placement of bone implants, today announces its 2024 financial agenda.
Financial Agenda 2024*
– Annual turnover 2023: January 10, 2024
– 2023 annual results: April 17, 2024
– 1st quarter 2024 turnover: April 17, 2024
– Annual General Meeting: June 5, 2024 (1st convocation) / June 26, 2024 (2nd convocation if applicable)
– Revenue for the first half of 2024 July 10, 2024
– First half 2024 results: September 11, 2024
– Turnover 3rd quarter 2024: October 9, 2024
Note
: any publication will be made after the markets close. Information subject to change.
To receive all of SpineGuard’s financial information in real time, request it by email to [email protected].
Source link -86